|
Apr 15
|
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
|
|
Apr 14
|
High Growth Tech Stocks In US With Potential For Expansion
|
|
Apr 14
|
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
|
|
Apr 12
|
Natera (NasdaqGS:NTRA) Climbs 11% in One Week
|
|
Apr 10
|
When Will Natera, Inc. (NASDAQ:NTRA) Turn A Profit?
|
|
Mar 14
|
Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value
|
|
Mar 14
|
Exploring Three High Growth Tech Stocks In The US Market
|
|
Mar 13
|
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board
|
|
Mar 11
|
Why Is Natera (NTRA) Stock Soaring Today
|
|
Mar 10
|
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
|
|
Feb 24
|
Natera, Inc. (NTRA): Among Top Stocks to Buy of Joe DiMenna’s Portfolio
|
|
Feb 19
|
Natera (NTRA) Surged on Blowout Quarterly Results
|
|
Feb 18
|
Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025
|
|
Feb 14
|
Schrodinger Stock Scores IBD Rating Upgrade
|
|
Feb 10
|
NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma
|
|
Jan 3
|
Six IBD 50 Stocks Bear Gifts Even As Santa Claus Rally Fizzles
|
|
Jan 3
|
High Growth Tech Stocks To Watch In January 2025
|
|
Jan 3
|
3 US Stocks That May Be Trading At A Discount
|
|
Jan 1
|
Natera's (NASDAQ:NTRA) investors will be pleased with their enviable 353% return over the last five years
|
|
Nov 15
|
Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have Been Lifting Their Price Targets
|